Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

αCAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice.

Eleftheriadou I, Manolaras I, Irvine EE, Dieringer M, Trabalza A, Mazarakis ND.

Ann Clin Transl Neurol. 2016 Sep 7;3(10):752-768. eCollection 2016 Oct.

2.

Potential new complication in drug therapy development for amyotrophic lateral sclerosis.

Garbuzova-Davis S, Thomson A, Kurien C, Shytle RD, Sanberg PR.

Expert Rev Neurother. 2016 Dec;16(12):1397-1405. Epub 2016 Jul 15.

PMID:
27362330
3.
4.

Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.

Tsai LK, Chen CL, Ting CH, Lin-Chao S, Hwu WL, Dodge JC, Passini MA, Cheng SH.

Mol Ther. 2014 Aug;22(8):1450-9. doi: 10.1038/mt.2014.84. Epub 2014 May 12.

5.

The association between cancer and amyotrophic lateral sclerosis.

Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA.

Cancer Causes Control. 2013 Jan;24(1):55-60. doi: 10.1007/s10552-012-0089-5. Epub 2012 Oct 23.

6.

Neuromuscular effects of G93A-SOD1 expression in zebrafish.

Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG, Dowling JJ, Feldman EL.

Mol Neurodegener. 2012 Aug 31;7:44. doi: 10.1186/1750-1326-7-44.

7.

Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.

Krakora D, Macrander C, Suzuki M.

Neurol Res Int. 2012;2012:379657. doi: 10.1155/2012/379657. Epub 2012 Aug 7.

8.

IGF-1 restores visual cortex plasticity in adult life by reducing local GABA levels.

Maya-Vetencourt JF, Baroncelli L, Viegi A, Tiraboschi E, Castren E, Cattaneo A, Maffei L.

Neural Plast. 2012;2012:250421. doi: 10.1155/2012/250421. Epub 2012 Jun 6.

9.

Intercellular (mis)communication in neurodegenerative disease.

Garden GA, La Spada AR.

Neuron. 2012 Mar 8;73(5):886-901. doi: 10.1016/j.neuron.2012.02.017. Review.

10.

Stem cell technology for the study and treatment of motor neuron diseases.

Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL.

Regen Med. 2011 Mar;6(2):201-13. doi: 10.2217/rme.11.6. Review. Erratum in: Regen Med. 2011 Jul;6(4):536.

11.
12.

Current and emerging treatments for amyotrophic lateral sclerosis.

Zoccolella S, Santamato A, Lamberti P.

Neuropsychiatr Dis Treat. 2009;5:577-95. Epub 2009 Nov 16.

13.

Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Lim ST, Airavaara M, Harvey BK.

Pharmacol Res. 2010 Jan;61(1):14-26. doi: 10.1016/j.phrs.2009.10.002. Epub 2009 Oct 17. Review.

14.

Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise.

Duman CH, Schlesinger L, Terwilliger R, Russell DS, Newton SS, Duman RS.

Behav Brain Res. 2009 Mar 17;198(2):366-71. doi: 10.1016/j.bbr.2008.11.016. Epub 2008 Nov 14.

Supplemental Content

Support Center